ABBV-221 T29517
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
ABBV-221 is an intravenously administered drug that modulates the activity of epidermal growth factor receptor (EGFR) and has potential antitumor activity.
CAS nr:
1165741-01-4
Purity:
98%
Molecular Weight:
SMILES:
NA
Formula:
Pathway:
Target:
